Research Papers: Immunology:
Avian leukosis virus subgroup J induces VEGF expression via NF-κB/PI3K-dependent IL-6 production
Metrics: PDF 519 views | HTML 255 views | ?
Yanni Gao1, Yao Zhang1, Yongxiu Yao2, Xiaolu Guan1, Yongzhen Liu1, Xiaole Qi1, Yongqiang Wang1, Changjun Liu1, Yanping Zhang1, Honglei Gao1, Venugopal Nair2, Xiaomei Wang1 and Yulong Gao1
1 Division of Avian Infectious Diseases, State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China
2 Avian Viral Diseases programme & UK-China Centre of Excellence on Avian Disease Research, The Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK
Yulong Gao, email:
Keywords: ALV-J, interleukin 6, tumorigenesis, VEGF-A, VEGFR-2, Immunology and Microbiology Section, Immune response, Immunity
Received: July 13, 2016 Accepted: November 07, 2016 Published: November 10, 2016
Avian leukosis virus subgroup J (ALV-J) is an oncogenic virus causing hemangiomas and myeloid tumors in chickens. Interleukin-6 (IL-6) is a multifunctional pro-inflammatory interleukin involved in many types of cancer. We previously demonstrated that IL-6 expression was induced following ALV-J infection in chickens. The aim of this study is to characterize the mechanism by which ALV-J induces IL-6 expression, and the role of IL-6 in tumor development. Our results demonstrate that ALV-J infection increases IL-6 expression in chicken splenocytes, peripheral blood lymphocytes, and vascular endothelial cells. IL-6 production is induced by the ALV-J envelope protein gp85 and capsid protein p27 via PI3K- and NF-κB-mediated signaling. IL-6 in turn induced expression of vascular endothelial growth factor (VEGF)-A and its receptor, VEGFR-2, in vascular endothelial cells and embryonic vascular tissues. Suppression of IL-6 using siRNA inhibited the ALV-J induced VEGF-A and VEGFR-2 expression in vascular endothelial cells, indicating that the ALV-J-induced VEGF-A/VEGFR-2 expression is mediated by IL-6. As VEGF-A and VEGFR-2 are important factors in oncogenesis, our findings suggest that ALV-J hijacks IL-6 to promote tumorigenesis, and indicate that IL-6 could potentially serve as a therapeutic target in ALV-J infections.
Primary Contact _
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.